Optomed Oyj - Total number of voting rights and capital

New shares subscribed for in Optomed Plc's directed share issue have been registered in the Finnish Trade Register

OPTOMED PLCSTOCK EXCHANGE RELEASE1 July 2024, at 8:30 a.m. EEST

New shares subscribed for in Optomed Plc's directed share issue have been
registered in the Finnish Trade Register

A total of 1,500,000 new shares subscribed for in Optomed Plc's directed share
issue have been registered into the Finnish Trade Register today, on 1 July
2024. After the registration of the new shares, the company will have 19,630,397
shares in total of which 353,973 shares in treasury.

The new shares produce the right to dividends and other distribution of assets
as well as other shareholder rights as of this registration date.

The new shares will be admitted to trading on the official list of Nasdaq
Helsinki Ltd today.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Distribution

Nasdaq Helsinki Ltd

Principal media

www.optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld cameras with software and
artificial intelligence with the aim to transform the diagnostic process of
blinding eye diseases such as rapidly increasing diabetic retinopathy. In its
business Optomed focuses on eye screening devices and software solutions related
R&D in Finland and sales through different channels in over 60 countries.